Next Article in Journal
Intra-Palpebral Tuberculin Skin Test and Interferon Gamma Release Assay in Diagnosing Tuberculosis Due to Mycobacterium caprae in European Bison (Bison bonasus)
Next Article in Special Issue
Peculiarities of Zika Immunity and Vaccine Development: Lessons from Dengue and the Contribution from Controlled Human Infection Model
Previous Article in Journal
Nematode Orthologs of Macrophage Migration Inhibitory Factor (MIF) as Modulators of the Host Immune Response and Potential Therapeutic Targets
Previous Article in Special Issue
Factors Possibly Associated with Mortality in Intubated COVID-19 Patients: A Retrospective Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Deciphering the Interactions of SARS-CoV-2 Proteins with Human Ion Channels Using Machine-Learning-Based Methods

1
Institute of Bioinformatics, International Technology Park, Bangalore 560066, India
2
Center for Molecular Medicine, National Institute of Mental Health and Neurosciences (NIMHANS), Hosur Road, Bangalore 560029, India
3
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
4
Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA
5
Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, Hauz Khas, New Delhi 110016, India
6
Manipal Academy of Higher Education (MAHE), Udupi 576104, India
*
Author to whom correspondence should be addressed.
Pathogens 2022, 11(2), 259; https://doi.org/10.3390/pathogens11020259
Submission received: 30 December 2021 / Revised: 31 January 2022 / Accepted: 8 February 2022 / Published: 17 February 2022
(This article belongs to the Special Issue Viral Pathogenesis and Immunity)

Abstract

:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is accountable for the protracted COVID-19 pandemic. Its high transmission rate and pathogenicity led to health emergencies and economic crisis. Recent studies pertaining to the understanding of the molecular pathogenesis of SARS-CoV-2 infection exhibited the indispensable role of ion channels in viral infection inside the host. Moreover, machine learning (ML)-based algorithms are providing a higher accuracy for host-SARS-CoV-2 protein–protein interactions (PPIs). In this study, PPIs of SARS-CoV-2 proteins with human ion channels (HICs) were trained on the PPI-MetaGO algorithm. PPI networks (PPINs) and a signaling pathway map of HICs with SARS-CoV-2 proteins were generated. Additionally, various U.S. food and drug administration (FDA)-approved drugs interacting with the potential HICs were identified. The PPIs were predicted with 82.71% accuracy, 84.09% precision, 84.09% sensitivity, 0.89 AUC-ROC, 65.17% Matthews correlation coefficient score (MCC) and 84.09% F1 score. Several host pathways were found to be altered, including calcium signaling and taste transduction pathway. Potential HICs could serve as an initial set to the experimentalists for further validation. The study also reinforces the drug repurposing approach for the development of host directed antiviral drugs that may provide a better therapeutic management strategy for infection caused by SARS-CoV-2.

1. Introduction

The COVID-19 pandemic rapidly spread to more than 175 countries within the first three months of its outbreak [1]. As of October 2021, more than 234 million cases have been reported, including 4.8 million deaths worldwide [2]. The dearth of approved treatments specific for SARS-CoV-2 infection impeded disease containment measures and control of the spread of infection. Viruses with small-sized genomes in particular, depend on the host genomic machinery for many of their essential functions via interacting with membrane proteins [3]. Human ion channels (HICs) are transmembrane proteins that allow the passive flow of ions across cellular membranes owing to their electrochemical gradient. This exchange of ions across the membrane results in electrical currents that contribute to a diverse set of roles, including the generation of membrane potential and cellular activities, such as signal transduction, synaptic release of neurotransmitters, and apoptosis [4]. Numerous viral infections involved in neuronal pathologies, diarrhoea, cardiomyopathies, bronchitis and pain disorders exploit a variety of HICs [3].
Ebola and influenza viruses exploit HICs to enter the host by utilizing Ca2+ channels [5,6]. Bunyamwera virus activates host potassium channels during the first six hours of its infection cycle [7]. The use of verapamil, L-type voltage gated Ca2+ channel inhibitor, in the treatment of infections caused by filoviruses further implicates the importance of HICs in viral survival [7]. Most likely, in order to survive and replicate inside a host, viruses must exploit the cellular environment, which is highly dependent on the flow of ions into and out of the cell [8]. The entry of SARS-CoV-2 exploits HICs as the conformational changes occurring in viral S protein prior to entering into the endosomes and fusion with the lysosomal membranes is promoted by calcium ions [9,10,11]. This further results in the elevation of cytosolic calcium concentration and aids in viral replication by inhibiting host protein trafficking and the maturation of viral proteins [12,13,14]. Advances in HIC-viral interaction studies provide insights into channelopathies, which may explain some commonly observed virus-induced pathologies [3]. The systematic mapping of PPIs of SARS-CoV-2 and human proteins was studied by Gordon et al. for exploring host dependencies of the SARS-CoV-2 [8]. Additionally, PPIs between SARS-CoV-2 proteins and human proteins implementing ML approaches were studied [15,16,17]. ML-based approaches in predicting interactions allow experimentalists to carry out further analysis with an improved efficacy of PPIs [18].
The current study focuses on understanding the interactome of SARS-CoV-2 proteins with HICs through in silico approaches. PPIs of SARS-CoV-2 proteins with HICs were trained on the PPI-MetaGO algorithm to associate the proteins based on its features. Later, PPI networks (PPINs) of SARS-CoV-2 proteins with HICs were generated. Thereafter, a biological pathway analysis of HICs interacting with SARS-CoV-2 proteins was performed and a pathway map depicting the role of HICs upon interactions with SARS-CoV-2 proteins was generated. Furthermore, FDA-approved drugs interacting with potential HICs were identified. The study may provide an insight to better understand the interactome of SARS-CoV-2 proteins with HICs and may unravel the development of future therapeutic strategies against SARS-CoV-2 infection. The study also underlines the potential significance of repurposing of drugs.

2. Results

A total of 181 interactions of HICs with SARS-CoV-2 proteins and 21 interactions among SARS-CoV-2 proteins were obtained from the BioGRID database (release 4.92.192) (Table S1). Thus, 404 interactions consisting of positive dataset (202 interactions) and negative dataset (202 interactions) were used as input for PPI-MetaGO.

2.1. Predictions of Protein–Protein Interactions of SARS-CoV-2 Proteins with HICs

SARS-CoV-2 and HIC interactions were predicted with an accuracy of 84.09% and AUC of 0.89 (Table 1). Confusion matrix obtained for the dataset represents 37 true positives, 7 false positives, 7 false negatives, and 30 true negatives (Table 2).

2.2. Protein–Protein Interaction Networks (PPINs) of HICs with SARS-CoV-2 Proteins

Of the 328 HICs, 40 were found to interact with 15 SARS-CoV-2 proteins. The functions of 40 HICs interacting with SARS-CoV-2 proteins are listed in Table S2.

2.2.1. Protein-Protein Interaction Maps and Networks

PPI maps of HICs-SARS-CoV-2 proteins are depicted in Figure 1. PPIs of all the SARS-CoV-2 proteins with HICs are shown as a network in Figure S1.
The HICs were found to interact with multiple SARS-CoV-2 proteins.

Interactions of Inositol 1,4,5-Trisphosphate Receptors (ITPRs) with SARS-CoV-2 Proteins

ITPRs are the major receptors involved in the release of calcium from the endoplasmic reticulum (ER) [19,20,21,22]. SARS-CoV-2 E, M, ORF7b, ORF7a and nsp4 proteins (Figure 1A,C,D,G,I) interacted with ITPR1, ITPR2 and ITPR3. Nsp6 and ORF8 (Figure 1H,J) interacted with ITPR2 and ITPR3. Additionally, S and ORF6 (Figure 1B,F) interacted with ITPR3.

Interactions of Leucine Rich Volume Regulated Anion Channels (LRRCs) with SARS-CoV-2 Proteins

LRRCs are involved in the development and functions of immune cells [23]. E, M, ORF7b, ORF3a, ORF7a, nsp6, nsp4 and ORF8 SARS-CoV-2 proteins (Figure 1A,C–E,G–J) interacted with LRRC8A.

Interactions of Voltage Dependent Anion Channels (VDACs) with SARS-CoV-2 Proteins

VDACs control the flow of Ca2+ ions from the mitochondrial membrane [24]. M, ORF3a, nsp6 and nsp4 (Figure 1C,D,H,I) interacted with VDAC2 and VDAC3. E, ORF7b, ORF6, ORF7a, nsp14, nsp5 and nsp13 (Figure 1A,D,F,G,L–N) interacted with VDAC3.

Interactions of Gap Junctions (GJ) with SARS-CoV-2 Proteins

GJ allow the intercellular flow of Ca2+ ions and enable communication between adjacent cells [25]. M, nsp4, nsp6, ORF7a and ORF7b viral proteins (Figure 1C,D,G–I) interacted with GJA1.

Interactions of Anoctamins (ANO) with SARS-CoV-2 Proteins

ANO are calcium-dependent chloride channel proteins. SARS-CoV-2 E, S, M, ORF7b, ORF7a, nsp6, nsp4 and ORF8 (Figure 1A–D,G–J) interacted with ANO6 and ANO10. Additionally, ORF3a and ORF6 (Figure 1E,F) interacted with ANO6.

Interactions of Transient Receptor Potential Cation Channels (TRPs) with SARS-CoV-2 Proteins

Proteins belonging to TRP family have a role in signal transductions [26,27,28], indicating their importance in cellular communications. TRPM7 is an ion channel as well as a serine/threonine protein kinase [29]. E, S, M, ORF7b, ORF6, ORF7a, nsp6, nsp4 and ORF8 (Figure 1A–D,F–J) interacted with TRPM7. PKD2 also known as TRPP2, a calcium permeable cation channel, interacted with E, M, ORF7b, ORF7a, nsp6 and nsp4 (Figure 1A,C,D,G–I).

2.2.2. Intra Protein Interactions

The Intra Protein Interactions among the 40 HICs Were Generated as PPINs Using STRING Database (v11) [30] to Identify the HICs that Most Likely Function in an Inter-dependent Manner While Performing a Biological Process. Furthermore, PPINs Were Overlaid with SARS-CoV-2 Proteins and Were Visualized Using Cytoscape (Figure 2).
Several identified HICs were reported in various cellular processes that aid in viral replication and survival. These processes could be the outcome of interactions among the HICs along with the interactions between HICs and SARS-CoV-2 proteins.

Role of ITPRs

Viruses exploiting ITPRs were reported to affect the host by increasing metabolic stress and enterotoxicity [31]. Additionally, viral infections promoted depletion of ER Ca2+ storage using ITPRs that in turn promoted viral replication [31]. The interaction of SARS-CoV-2 proteins with ITPRs may promote viral replication inside the host cells.

Role of LRRCs

LRRCs played important roles in T-cell/ B-cell and lymphocyte function and development [23]. Thus, the identified interactions between LRRC8A and SARS-CoV-2 proteins may play roles in the impairment of T-cell development during the course of infection. These proteins were also reported for their involvement in the maintenance of constant cell volume, efflux of amino acids and import of antibiotic blasticidin-S into the cells [32,33,34,35,36,37].

Role of VDACs

VDACs were reported for their involvement in the transportation of metabolites from mitochondria to ER during viral replication and interacted with the structural and non-structural proteins (nsps) of dengue virus [24].

Role of GJs

Host cell junctions were reported to be destroyed by viruses during invasion [25]. Another role of GJs reported in viral infection was the amplification of antiviral signaling in neighboring cells. It was studied that STING-dependent recognition was essential for limiting virus replication in the influenza virus [23]. Thus, it could be inferred that gap junctions could act as a port of entry for the virus and further limit the immune reaction against SARS-CoV-2 infection [38]. Most likely, GJA1 may be involved in the cell-to-cell spread of the virus. Additionally, gap junction proteins play a major role in the contraction of the heart [39,40,41]. Thus, they could have a role in the predisposition of the cardiac arrythmias observed during viral infections [42].

Role of Other Significant HICs

Other important HICs found were the potassium voltage gated channels that were known to act as modulators of potassium flow into the cell and also had roles in the reactivation of naïve T cells [43,44,45,46,47,48,49,50,51,52,53,54]. The HICs that belonged to voltage-dependent anion channels controlled the flow of Ca2+ ions during viral entry [6,24,55]. The chloride voltage gated channels helped to maintain homeostasis and also contributed to acidification, thus maintaining lysosomal pH [55,56,57,58,59]. Anoctamins may be responsible for the entry of viral proteins into the cells [60,61,62,63,64,65,66]. ASIC1, generally involved in learning, pain, sensation, memory and fear [67], was also identified. TPCN1, HCN2, SCN9A, GRID1, CHRNA5 and MCOLN3 were also present. These proteins function as voltage-gated calcium channels across lysosomal membranes, native pacemaker currents in heart, sodium-selective channels that allowed Na+ to pass as per the electrochemical gradient, channels at synapses and cation channels for inwardly rectifying activity, respectively [68,69,70,71,72,73,74]. The glycine receptor beta protein found was a member of ligand gated chloride channels [75]. The GABRA5, a component of heteropentameric receptor for gamma-aminobutyric acid (GABA), was involved in GABA-A receptor assembly [76].

2.3. Pathway Analysis of 40 HICs Interacting with SARS-CoV-2 Proteins

Pathway analysis of 40 HICs was performed using the STRING database to gather functional insights about the processes regulated by the HICs. Forty-six biological pathways corresponding to the KEGG PATHWAY database were identified. Inflammatory mediator regulation of TRP channels, insulin secretion, renin secretion, pathways involving gap junction, taste transduction, calcium signaling pathway, apelin signaling pathway and GnRH secretion were selected as significant pathways (Table 3).

2.4. Signaling Pathway Map of HICs with SARS-CoV-2 Proteins

The advent of omics technologies led to an enormous progress in the generation of signaling pathways [77]. The pathway map of SARS-CoV was generated as a source that could aid in the understanding of viral entry into the cell and the lifecycle of the virus in infected cells [78]. A signaling pathway map for the HICs interacting with SARS-CoV-2 proteins (Figure 3) was generated based on data mining approaches. SARS-CoV-2 entry involves various interactions of the S1-subunit of viral S protein with angiotensin converting enzyme 2 receptors (ACE2) of human cell and transmembrane protease-serine 2 (TMPRSS) receptors that aid in virus–cell membrane fusion. This fusion accompanied by conformational changes of S protein allowed the insertion of fusion peptide into the lipid bilayer and was promoted by Ca+2 ions [11]. The interaction of viral proteins with ACE2 may further lead to hypoxic conditions. Renin-angiotensin aldosterone-system, which includes renin as the key regulator in the maintenance of extracellular fluid volume and blood pressure homeostasis, is secreted in the juxta-glomerular cells. This secretion was mainly controlled by free cytosolic Ca+2 concentrations. Renin also catalyzed the conversion of AGT to angiotensin I. The release of interleukins may be further stimulated by angiotensin receptors activated upon the conversion of angiotensin I to angiotensin II catalyzed by ACE protein [79]. The orchestration of renin-induced reactions may lead to acute lung injury [79]. Glucose-stimulated insulin secretion is an important mechanism in regulating glucose homeostasis. This process involved the generation of ATP that inhibited ATP-sensitive K+ channels and caused voltage-dependent Ca+2 influx [80]. The reduction in the number of insulin secretory granules and thus impaired glucose stimulated insulin secretion during the course of infection [81] may be attributed to this mechanism. GJA1 functions in the intracellular transport of Ca+2 ions and thus change in the level of Ca+2 ions may act as stimuli for communication by GJA1. Various L-type calcium channels (CACNA1C, CACNA1D, CACNA1S and CACNA1F) mediate the influx of intracellular Ca+2 ions. Intracellular Ca+2 induced the Raf/MEK/ERK pathway that regulated the transcription of COX2 and led to inflammation reactions [82]. Additionally, the transcription of gonadotropins is regulated through the Raf/MEK/ ERK pathway. The reduced level of testosterone production in COVID-19 patients was associated with altered secretion of gonadotropins [83]. The mobilization of Ca+2 from endoplasmic reticulum was regulated by ITPRs and from mitochondria by VDACs. Additionally, calcium was released from Ca+2 acidic stores through TPCNs and MCOLNs. Na+ and Ca+2 ions influx was facilitated by TRP channels and ASIC1. TRP channels may lead to pain, hyperinflammation, and oxidative stress [84]. The influx of K+ ions by KCN and HCN channels was stimulated by Na+. The PLCB2/ITP3 signaling cascade mediated the transduction of bitter, sweet and umami taste by opening of TRPM5 followed by depolarization of plasma membrane that allowed the influx of Na+ ions. Furthermore, Na+ influx prevailed due to the SCN membrane channels. SCN channels interacted with CALHM1 and contributed in the mechanism related to taste inception. Thus, the loss of taste occurring in COVID-19 patients may be linked to the deregulation of these channels.

2.5. Drugs Interacting with Potential HICs

HICs interacting with viral proteins could be potential drug targets for drug repurposing. Additionally, the traditional drug development method is considerably expensive and time consuming. Drug repurposing is an efficacious process by which effective drugs can be identified. A list of FDA-approved drugs interacting with HICs and SARS-CoV-2 protein is listed in Table S3. Drugs interacting with HICs are depicted on HICs-SARS-CoV-2 PPINs highlighting potential drug targets (Figure 4).

3. Discussion

Studies pertaining to the development of novel therapeutic strategies are of utmost importance to combat the heterogeneity in the infection caused by SARS-CoV-2. The current study aimed to understand the interactome of SARS-CoV-2 proteins and HICs through various bioinformatic analyses. It is known that the coronavirus family uses the E protein to induce intracellular membrane remodelling, generating new membrane vesicles that serve as a viral replication site responsible for the depolarisation of membranes [85]. Furthermore, the E protein also helps to bud and release virus particles [85]. Likewise, the M protein along with E protein is responsible for the determination of virion assembly [85]. The nsp3, nsp4 and nsp6, involved in host membrane remodelling and known to act as membrane anchors for replication and transcription complexes, were reported to contain a transmembrane domain [86,87]. This could shed light on the fact that these viral proteins have similar properties as those of HICs and may be involved in host invasion by mimicking the ion channels present in the host. This could be attributed to the presence of a signature sequence in the chlorella virus (PBCV-1) Kcv protein that showed architectural similarity with eukaryotic Kir channels [88]. Hence, it is important to understand the function of viroporins in the manipulation of host-specific processes. However, targeting them can be a challenge due to the resistance polymorphism exhibited by viruses.
Several host pathways were found to be altered due to interactions between SARS-CoV-2 proteins with HICs. Inflammatory mediator regulations of TRP channels pathway include TRP channels (ITPR1, ITPR2 and ITPR3). TRP channels that respond to temperature are known as thermo-TRPs. Among them, TRPA1, TRPM8, and TRPV1-4 are found in the nerve endings and play a major role in pain perception. These proteins are modulated indirectly by inflammatory mediators such as proinflammatory cytokines [89]. The activation of TRPV1 increases the release of several pro-inflammatory molecules, including substance P (sP) and cytokines, such as interleukin-6. Respiratory pathophysiology in SARS-CoV-2 infection may involve TRPV1 receptor sensitization that could result in hyper inflammation of the lungs and associated complications [90]. TRP channels also play a role in the transmission of sensory stimuli of taste [91]. Thus, TRPA1 may increase the sensitivity to evoke pain and several other symptoms associated with SARS-CoV-2 infection [91]. ACE2 and TMPRSS2 expression has been reported in the salivary gland cells of the tongue and tonsils. It might allow the virus to fuse its membrane with the host cells as compared to other oral tissues [92]. SARS-CoV-2 may cause changes in the production or quality of saliva, contributing to the symptoms of loss of taste in the oral cavity of infected patients.
Glucose-induced insulin secretion is the main principle of insulin release [80]. Deterioration in glycemic levels including both insulin resistance and impaired insulin secretion were recently reported upon SARS-CoV-2 infection [93,94]. Additionally, a recent study showed that ACE2 expression increased considerably in human pancreatic beta cells in response to inflammatory cytokines, thus rendering the beta cells more susceptible to SARS-CoV-2 infections [81]. Hence, the roles of HICs, including TRPM4, KCNN4, KCNJ11 and ITPR3, need to be explored further regarding this mechanism.
Gap junctions contain the intercellular channels that allow a direct communication between the cellular compartments. These channels permit the transfer of ions, amino acids, secondary messengers and other metabolites between adjacent cells. Changes in the intracellular Ca2+ levels act as stimuli to the gap junctions. ITPRs (ITPR1, ITPR2, ITPR3) play a crucial role in maintaining the intracellular Ca2+as they act on the ER for the regulation of cytoplasmic calcium concentration [95].
The renin-angiotensin-aldosterone system (RAAS) is an essential system for electrolyte homeostasis and blood pressure management through the ACE2 axis. The deregulation of RAAS homeostasis results in the development of distress in lungs, induced apoptosis, vasoconstriction, increased oxidative stress and edema [79]. ACE2 acts as a port of entry for SARS-CoV-2 and its expression decreases as the infection progresses [96]. The reduction in expression levels of ACE2 could be correlated to the increase in Ca2+-concentration-dependent metalloproteinase domain-containing protein (ADAM10). Moreover, the increase in Ca2+ concentration could further be attributed to viral proteins interacting with ITPR3 [97]. Additionally, the decrease in ACE2 level led to the accumulation of angiotensin II, which further activated the angiotensin II type 1 receptor (AT1R) axis, thus worsening the disease outcome. Additionally, apelin signaling could also be suggested to be involved in disease progression. Apelin peptides are endogenous ligands of G protein coupled receptors APJ. Apelin played a number of roles in the mammalian system by protecting cardiac health and calcium modulation [98]. Experimental studies exhibited that apelin administration had anti-inflammatory effects [97].
HICs interacting with viral proteins could be potential drug targets for drug repurposing. The identification of drugs that could be targeted against potential HICs was performed. However, drugs targeted against HICs can be toxic in some case [99]. Therefore, the identified drugs should be tested for the antiviral activity accordingly.

4. Material and Methods

An overview of the methodology followed to study the PPIs between SARS-CoV-2 and HICs is described in Figure 5.

4.1. Data Collection

One of the most crucial steps while building any model based on a ML algorithm is the extraction and enhancement of a good dataset. Primarily, a list of 28 unique SARS-CoV-2 proteins were downloaded from the RefSeq database and 328 HICs were retrieved from HGNC database [100]. Interactions between HICs and SARS-CoV-2 proteins were parsed using the BioGRID database (release 4.92.192). These interactions were considered as the positive dataset that were used as input for PPI-MetaGO. The binding affinity of each of the interactions predicted using In SiLico protein AffiNity predictor (ISLAND) [101] was included to scale the affinity between the interactors. There are no ‘gold standard’ negative datasets available. Therefore, for PPI prediction, usually protein pairs are chosen randomly from the set of protein pairs that are not known to interact, and treated as a negative dataset [102]. Hence, in this study for the negative set, first the complement graph of the positive interactions was made and random interactions were taken to generate the negative set. Furthermore, the protein sequences were parsed using RefSeq database and gene ontology terms for SARS-CoV-2 proteins were downloaded from Gene Ontology knowledgebase [103,104].

4.2. Feature Extraction and Stacked Generalisation Method for Model Generation

The PPI-MetaGO algorithm [105] was applied for the extraction of features of the protein pairs. It is an ensemble supervised meta learner algorithm for PPI prediction. It employs a hybrid feature representation combining the protein sequence properties, gene ontology information, and interaction network topology. The feature vectors consisting of physicochemical properties of proteins were extracted using protein sequences. The semantic similarities were extracted using the provided GO terms [105]. The dataset was split into a training and testing set in 80:20 ratios. Thereafter, protein sequences and the GO terms were provided as input to the PPI-MetaGO program for the calculation of features and model building. Customized Python scripts were used for the generation of input for PPI-MetaGO. PPI-MetaGO uses a stacked generalization method that allows combining multiple ML algorithms to maximize accuracy. The usage of a single ML-based method may lead to the overfitting or underfitting of data even when the parameters are optimized maximally. Bagging and boosting, which allow multiple ML-based algorithms, only permit the combination of algorithms of the same type and focus on reducing the variance from multiple classifiers [105]. Stacked generalization uses a meta-ML model that allows the combination of different algorithms and aims to reduce the bias of the base generalizers [106]. ML-based methods utilized by PPI-MetaGO include random forest (RF), artificial neural network (ANN), Naïve Bayes (NB), K-nearest neighbors (kNN) and support vector machine (SVM). RF consists of a set of decision trees/base regression trees that form an aggregated regression estimate. kNN classifier classifies unlabeled observations by assigning them to a class with the most similar labeled observation through calculation of distances between two datapoints. NB is a probability-based classifier that classifies a datapoint based on prior probability and likelihood calculations. ANN is a biologically inspired computational network that generates a pattern from the input dataset and provides an output based on those patterns. SVM is supervised learning algorithm that can simultaneously minimize the classification error and maximize the geometric margin between two classes. PPI-MetaGO uses a two-level stacked classifier approach where the bottom layer uses RF, kNN, NB and ANN. The top layer uses SVM with RBF kernel. The predictions from the bottom layer are passed as meta data for the top layer which makes the final prediction.

4.3. Evaluation of Predicted PPIs

To evaluate the performance of PPI-MetaGO, a 10-fold cross-validation was performed [105]. Additionally, the PPIs were evaluated using the following performance measures:
Accuracy = TP + TN TP + TN + FP + FN
Precision = TP TP + FP
F - score = 2   ×   TPR   ×   Precision TPR + Precision
MCC = TP   ×   TN - FP   ×   FN ( TP + FP ) ( TP + FN ) ( TN + FP ) ( TN + FN )
Sensitivity = TP TP + FN
False   Positive   Rate = FP FP + TN
where TPR, TP, TN, FP, and FN represent true positive rate, true positive, true negative, false positive, and false negative, respectively. In addition, PPI-MetaGO also calculates area under the curve (AUC). AUC is the probability that a random positive sample will have a higher score than a random negative sample.

4.4. Generation of PPI Maps

The PPIs among HICs-SARS-CoV-2 proteins and the PPI maps were visualized using Cytoscape-3.8 [107]. Additionally, PPINs of HICs interacting with SARS-CoV-2 proteins were generated using the STRING database (v11) [30]. Thereafter, the visualization of PPINs of HICs-SARS-CoV-2 proteins was performed using Cytoscape-3.8.

4.5. Pathway Analysis of HICs Interacting with SARS-CoV-2 Proteins

The KEGG PATHWAY analysis of HICs interacting with SARS-CoV-2 proteins was performed using the STRING database (v11). Significant pathways were selected based on statistical measures including strength and false discovery rate (FDR) score provided by p-values for further analysis.

4.6. Generation of Signaling Pathway Map of HICs with SARS-CoV-2 Proteins

An extensive literature search was performed using PubMed to annotate reactions such as protein–protein interactions, translocations, activations and inhibitions that describe HICs in association with SARS-CoV-2 proteins [78,108]. Several query terms were used including, “SARS-CoV-2” AND “ion channels”, “SARS-CoV-2” AND “human ion channels”, “SARS-CoV-2” AND “pathway” OR “signaling”. The articles were screened for information pertaining to biological pathways involving HICs interacting with SARS-CoV-2 proteins. The processes occurring in SARS-CoV-2 infected patients as compared to healthy individuals were included. Thereafter, a signaling pathway map of HICs interacting with SARS-CoV-2 was generated in Graphical Pathway Markup Language (GPML) format using PathVisio (version 3.3.0) [109], an opensource pathway drawing software. In the map, nodes describe the entity pool (proteins and genes) and edges represent the relationship between nodes.

4.7. Identification of Drugs Interacting with Potential HICs

FDA-approved drugs interacting with HICs were parsed using the Drug–Gene Interaction database (DGIdb) [110,111]. Furthermore, drugs interacting with HICs were depicted on HICs-SARS-CoV-2 PPINs to highlight potential drug targets.

5. Conclusions

Several computational approaches, including ML-based algorithms, were applied to study the interactome of SARS-CoV-2 proteins with HICs. Biological insights of HICs interacting with SARS-CoV-2 proteins were gained using pathway analysis. TRPM4 and KCNN4 were found to a play role in insulin secretion. TRPA1 was found as an important molecule in heat, pain, and taste sensitivity inside the host. GJA1 has a crucial role in pathways involving gap junctions and ASIC1 was found to be a part of inflammatory mediator regulation of TRP channels. ITPR1 was found to be involved in six predicted pathways, including inflammatory mediator regulation of TRP channels, gap junction, renin secretion and apelin signaling pathways. Moreover, FDA-approved drugs interacting with potential HICs were identified that can be repurposed. Most likely, our analyses showed promising results that further require experimental validation. HICs could be further explored as a potential class of targets for the better management of the infection caused by SARS-CoV-2.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/pathogens11020259/s1, Figure S1: Schematic depiction of interactions of total SARS-CoV-2 proteins with human ion channels; Table S1: A list of protein-protein interactions of SARS-CoV-2—human ion channels and SARS-CoV-2—SARS-CoV-2 proteins from BioGRID database (release 4.92.192) with the experimental evidences; Table S2: Function of human ion channels interacting with SARS-CoV-2 proteins; Table S3: A list of drugs interacting with HICs.

Author Contributions

Conceptualization, J.S.; methodology, N.S.M., D.S., K.T.S.P. and J.S.; formal analysis, N.S.M., D.S., K.T.S.P., A.G. and J.S.; data curation, N.S.M., D.S., K.T.S.P. and A.G.; writing-original draft preparation, N.S.M., K.T.S.P., A.G. and J.S.; writing-review and editing, N.S.M., K.T.S.P., M.B. and J.S.; visualization, K.T.S.P.; supervision, A.P., M.B. and J.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the intramural funds of Institute of Bioinformatics, India and Bio-CARe by Department of Biotechnology (DBT), Government of India, grant number BT/PR19924/BIC/101/568/2016.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Publicly available datasets were analyzed in this study. The data can be accessible using following resources: RefSeq database (https://www.ncbi.nlm.nih.gov/refseq/, accessed on 18 March 2021), BioGRID database (https://thebiogrid.org/, accessed on 3 March 2021) and Gene Ontology knowledgebase (http://geneontology.org/, accessed on 18 March 2021). Customized Python scripts used for PPI data analysis and the HICs-SARS-CoV-2 pathway reaction data are available in GPML format through GitHub repository (https://github.com/js-iob/HICs-SARS-CoV-2_PPIs/blob/main/HICs_SARS_CoV2_Signaling_Pathway_map.gpml and https://github.com/js-iob/HICs-SARS-CoV-2_PPIs/blob/main/HICs_SARS_CoV2_data_files.rar, accessed on 20 October 2021).

Acknowledgments

The authors thank the Department of Biotechnology (DBT), Government of India for research support to the Institute of Bioinformatics (IOB), Bangalore. J.S. was a recipient of Bio-CARe Women Scientists award by Department of Biotechnology (DBT), Government of India (Grant number-BT/PR19924/BIC/101/568/2016).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. [Google Scholar] [CrossRef] [Green Version]
  2. Coronavirus Resource Center. Available online: https://coronavirus.jhu.edu/ (accessed on 8 October 2021).
  3. Charlton, F.W.; Pearson, H.M.; Hover, S.; Lippiat, J.D.; Fontana, J.; Barr, J.N.; Mankouri, J. Ion Channels as Therapeutic Targets for Viral Infections: Further Discoveries and Future Perspectives. Viruses 2020, 12, 844. [Google Scholar] [CrossRef] [PubMed]
  4. Kim, J.B. Channelopathies. Korean J. Pediatr. 2014, 57, 1–18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Simmons, J.A.; D’Souza, R.S.; Ruas, M.; Galione, A.; Casanova, J.E.; White, J.M. Ebolavirus Glycoprotein Directs Fusion through NPC1+ Endolysosomes. J. Virol. 2015, 90, 605–610. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Fujioka, Y.; Nishide, S.; Ose, T.; Suzuki, T.; Kato, I.; Fukuhara, H.; Fujioka, M.; Horiuchi, K.; Satoh, A.O.; Nepal, P.; et al. A Sialylated Voltage-Dependent Ca(2+) Channel Binds Hemagglutinin and Mediates Influenza A Virus Entry into Mammalian Cells. Cell Host Microbe 2018, 23, 809–818.e805. [Google Scholar] [CrossRef] [Green Version]
  7. Hover, S.; Foster, B.; Barr, J.N.; Mankouri, J. Viral dependence on cellular ion channels—An emerging anti-viral target? J. Gen. Virol. 2017, 98, 345–351. [Google Scholar] [CrossRef] [Green Version]
  8. Gordon, D.E.; Jang, G.M.; Bouhaddou, M.; Xu, J.; Obernier, K.; White, K.M.; O’Meara, M.J.; Rezelj, V.V.; Guo, J.Z.; Swaney, D.L.; et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020, 583, 459–468. [Google Scholar] [CrossRef]
  9. Li, F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu. Rev. Virol. 2016, 3, 237–261. [Google Scholar] [CrossRef] [Green Version]
  10. Perlman, S.; Netland, J. Coronaviruses post-SARS: Update on replication and pathogenesis. Nat. Rev. Microbiol. 2009, 7, 439–450. [Google Scholar] [CrossRef] [Green Version]
  11. Navarese, E.P.; Musci, R.L.; Frediani, L.; Gurbel, P.A.; Kubica, J. Ion channel inhibition against COVID-19: A novel target for clinical investigation. Cardiol. J. 2020, 27, 421–424. [Google Scholar] [CrossRef]
  12. Jayaseelan, V.P.; Paramasivam, A. Repurposing calcium channel blockers as antiviral drugs. J. Cell Commun. Signal. 2020, 14, 467–468. [Google Scholar] [CrossRef]
  13. Wang, H.; Yang, P.; Liu, K.; Guo, F.; Zhang, Y.; Zhang, G.; Jiang, C. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res. 2008, 18, 290–301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Glebov, O.O. Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing. FEBS J. 2020, 287, 3664–3671. [Google Scholar] [CrossRef]
  15. Dey, L.; Chakraborty, S.; Mukhopadhyay, A. Machine learning techniques for sequence-based prediction of viral-host interactions between SARS-CoV-2 and human proteins. Biomed. J. 2020, 43, 438–450. [Google Scholar] [CrossRef] [PubMed]
  16. Nourani, E.; Khunjush, F.; Durmus, S. Computational approaches for prediction of pathogen-host protein-protein interactions. Front. Microbiol. 2015, 6, 94. [Google Scholar] [CrossRef] [PubMed]
  17. Mei, S.; Zhang, K. In silico unravelling pathogen-host signaling cross-talks via pathogen mimicry and human protein-protein interaction networks. Comput. Struct. Biotechnol. J. 2019, 18, 100–113. [Google Scholar] [CrossRef]
  18. Sarkar, D.; Saha, S. Machine-learning techniques for the prediction of protein-protein interactions. J. Biosci. 2019, 44, 104. [Google Scholar] [CrossRef]
  19. Atakpa, P.; Thillaiappan, N.B.; Mataragka, S.; Prole, D.L.; Taylor, C.W. IP3 Receptors Preferentially Associate with ER-Lysosome Contact Sites and Selectively Deliver Ca(2+) to Lysosomes. Cell Rep. 2018, 25, 3180–3193.e3187. [Google Scholar] [CrossRef] [Green Version]
  20. Wiel, C.; Lallet-Daher, H.; Gitenay, D.; Gras, B.; Le Calve, B.; Augert, A.; Ferrand, M.; Prevarskaya, N.; Simonnet, H.; Vindrieux, D.; et al. Endoplasmic reticulum calcium release through ITPR2 channels leads to mitochondrial calcium accumulation and senescence. Nat. Commun. 2014, 5, 3792. [Google Scholar] [CrossRef] [Green Version]
  21. Vervloessem, T.; Yule, D.I.; Bultynck, G.; Parys, J.B. The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca(2)(+)-release channel. Biochim. Biophys. Acta 2015, 1853, 1992–2005. [Google Scholar] [CrossRef] [Green Version]
  22. Kuchay, S.; Saeed, M.; Giorgi, C.; Li, J.; Hoffmann, H.H.; Pinton, P.; Rice, C.M.; Pagano, M. NS5A Promotes Constitutive Degradation of IP3R3 to Counteract Apoptosis Induced by Hepatitis C Virus. Cell Rep. 2018, 25, 833–840.e833. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Platt, C.D.; Chou, J.; Houlihan, P.; Badran, Y.R.; Kumar, L.; Bainter, W.; Poliani, P.L.; Perez, C.J.; Dent, S.Y.R.; Clapham, D.E.; et al. Leucine-rich repeat containing 8A (LRRC8A)-dependent volume-regulated anion channel activity is dispensable for T-cell development and function. J. Allergy Clin. Immunol. 2017, 140, 1651–1659.e1651. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Jitobaom, K.; Tongluan, N.; Smith, D.R. Involvement of voltage-dependent anion channel (VDAC) in dengue infection. Sci. Rep. 2016, 6, 35753. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Dong, D.; Xie, W.; Liu, M. Alteration of cell junctions during viral infection. Thorac. Cancer 2020, 11, 519–525. [Google Scholar] [CrossRef]
  26. Zhao, J.; Lin King, J.V.; Paulsen, C.E.; Cheng, Y.; Julius, D. Irritant-evoked activation and calcium modulation of the TRPA1 receptor. Nature 2020, 585, 141–145. [Google Scholar] [CrossRef]
  27. Xian, W.; Wang, H.; Moretti, A.; Laugwitz, K.L.; Flockerzi, V.; Lipp, P. Domain zipping and unzipping modulates TRPM4’s properties in human cardiac conduction disease. FASEB J. 2020, 34, 12114–12126. [Google Scholar] [CrossRef]
  28. Jha, R.M.; Desai, S.M.; Zusman, B.E.; Koleck, T.A.; Puccio, A.M.; Okonkwo, D.O.; Park, S.Y.; Shutter, L.A.; Kochanek, P.M.; Conley, Y.P. Downstream TRPM4 Polymorphisms Are Associated with Intracranial Hypertension and Statistically Interact with ABCC8 Polymorphisms in a Prospective Cohort of Severe Traumatic Brain Injury. J. Neurotrauma 2019, 36, 1804–1817. [Google Scholar] [CrossRef]
  29. Lee, C.T.; Ng, H.Y.; Kuo, W.H.; Tain, Y.L.; Leung, F.F.; Lee, Y.T. The role of TRPM7 in vascular calcification: Comparison between phosphate and uremic toxin. Life Sci. 2020, 260, 118280. [Google Scholar] [CrossRef]
  30. Szklarczyk, D.; Gable, A.L.; Lyon, D.; Junge, A.; Wyder, S.; Huerta-Cepas, J.; Simonovic, M.; Doncheva, N.T.; Morris, J.H.; Bork, P.; et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019, 47, D607–D613. [Google Scholar] [CrossRef] [Green Version]
  31. Clark, K.B.; Eisenstein, E.M. Targeting host store-operated Ca(2+) release to attenuate viral infections. Curr. Top. Med. Chem. 2013, 13, 1916–1932. [Google Scholar] [CrossRef]
  32. Chen, L.; Konig, B.; Liu, T.; Pervaiz, S.; Razzaque, Y.S.; Stauber, T. More than just a pressure relief valve: Physiological roles of volume-regulated LRRC8 anion channels. Biol. Chem. 2019, 400, 1481–1496. [Google Scholar] [CrossRef] [PubMed]
  33. Lu, J.; Xu, F.; Zhang, J. Inhibition of angiotensin II-induced cerebrovascular smooth muscle cell proliferation by LRRC8A downregulation through suppressing PI3K/AKT activation. Hum. Cell 2019, 32, 316–325. [Google Scholar] [CrossRef] [PubMed]
  34. Voss, F.K.; Ullrich, F.; Munch, J.; Lazarow, K.; Lutter, D.; Mah, N.; Andrade-Navarro, M.A.; von Kries, J.P.; Stauber, T.; Jentsch, T.J. Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC. Science 2014, 344, 634–638. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Lutter, D.; Ullrich, F.; Lueck, J.C.; Kempa, S.; Jentsch, T.J. Selective transport of neurotransmitters and modulators by distinct volume-regulated LRRC8 anion channels. J. Cell Sci. 2017, 130, 1122–1133. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Lee, C.C.; Freinkman, E.; Sabatini, D.M.; Ploegh, H.L. The protein synthesis inhibitor blasticidin s enters mammalian cells via leucine-rich repeat-containing protein 8D. J. Biol. Chem. 2014, 289, 17124–17131. [Google Scholar] [CrossRef] [Green Version]
  37. Schober, A.L.; Wilson, C.S.; Mongin, A.A. Molecular composition and heterogeneity of the LRRC8-containing swelling-activated osmolyte channels in primary rat astrocytes. J. Physiol. 2017, 595, 6939–6951. [Google Scholar] [CrossRef]
  38. Ahn, J.; Barber, G.N. STING signaling and host defense against microbial infection. Exp. Mol. Med. 2019, 51, 1–10. [Google Scholar] [CrossRef]
  39. Martins-Marques, T.; Catarino, S.; Goncalves, A.; Miranda-Silva, D.; Goncalves, L.; Antunes, P.; Coutinho, G.; Leite Moreira, A.; Falcao Pires, I.; Girao, H. EHD1 Modulates Cx43 Gap Junction Remodeling Associated With Cardiac Diseases. Circ. Res. 2020, 126, e97–e113. [Google Scholar] [CrossRef]
  40. Brink, P.R.; Valiunas, V.; White, T.W. Lens Connexin Channels Show Differential Permeability to Signaling Molecules. Int. J. Mol. Sci. 2020, 21, 6943. [Google Scholar] [CrossRef]
  41. Ye, W.G.; Yue, B.; Aoyama, H.; Kim, N.K.; Cameron, J.A.; Chen, H.; Bai, D. Junctional delay, frequency, and direction-dependent uncoupling of human heterotypic Cx45/Cx43 gap junction channels. J. Mol. Cell Cardiol. 2017, 111, 17–26. [Google Scholar] [CrossRef]
  42. Guzik, T.J.; Mohiddin, S.A.; Dimarco, A.; Patel, V.; Savvatis, K.; Marelli-Berg, F.M.; Madhur, M.S.; Tomaszewski, M.; Maffia, P.; D’Acquisto, F.; et al. COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 2020, 116, 1666–1687. [Google Scholar] [CrossRef] [PubMed]
  43. Fu, J.; Dai, X.; Plummer, G.; Suzuki, K.; Bautista, A.; Githaka, J.M.; Senior, L.; Jensen, M.; Greitzer-Antes, D.; Manning Fox, J.E.; et al. Kv2.1 Clustering Contributes to Insulin Exocytosis and Rescues Human beta-Cell Dysfunction. Diabetes 2017, 66, 1890–1900. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Yan, L.; Figueroa, D.J.; Austin, C.P.; Liu, Y.; Bugianesi, R.M.; Slaughter, R.S.; Kaczorowski, G.J.; Kohler, M.G. Expression of voltage-gated potassium channels in human and rhesus pancreatic islets. Diabetes 2004, 53, 597–607. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Mederos, Y.S.M.; Rinne, S.; Skrobek, L.; Renigunta, V.; Schlichthorl, G.; Derst, C.; Gudermann, T.; Daut, J.; Preisig-Muller, R. Mutation of histidine 105 in the T1 domain of the potassium channel Kv2.1 disrupts heteromerization with Kv6.3 and Kv6. J. Biol. Chem. 2009, 284, 4695–4704. [Google Scholar] [CrossRef] [Green Version]
  46. Du, Q.; Jovanovic, S.; Tulic, L.; Sljivancanin, D.; Jack, D.W.; Zizic, V.; Abdul, K.S.; Tulic, I.; Jovanovic, A. KATP channels are up-regulated with increasing age in human myometrium. Mech. Ageing Dev. 2013, 134, 98–102. [Google Scholar] [CrossRef]
  47. Delaney, J.T.; Muhammad, R.; Blair, M.A.; Kor, K.; Fish, F.A.; Roden, D.M.; Darbar, D. A KCNJ8 mutation associated with early repolarization and atrial fibrillation. Europace 2012, 14, 1428–1432. [Google Scholar] [CrossRef] [Green Version]
  48. Babenko, A.P.; Gonzalez, G.; Aguilar-Bryan, L.; Bryan, J. Reconstituted human cardiac KATP channels: Functional identity with the native channels from the sarcolemma of human ventricular cells. Circ. Res. 1998, 83, 1132–1143. [Google Scholar] [CrossRef] [Green Version]
  49. Tammaro, P.; Ashcroft, F.M. A mutation in the ATP-binding site of the Kir6.2 subunit of the KATP channel alters coupling with the SUR2A subunit. J. Physiol. 2007, 584, 743–753. [Google Scholar] [CrossRef]
  50. Cooper, P.E.; McClenaghan, C.; Chen, X.; Stary-Weinzinger, A.; Nichols, C.G. Conserved functional consequences of disease-associated mutations in the slide helix of Kir6.1 and Kir6.2 subunits of the ATP-sensitive potassium channel. J. Biol. Chem. 2017, 292, 17387–17398. [Google Scholar] [CrossRef] [Green Version]
  51. Srivastava, S.; Li, Z.; Ko, K.; Choudhury, P.; Albaqumi, M.; Johnson, A.K.; Yan, Y.; Backer, J.M.; Unutmaz, D.; Coetzee, W.A.; et al. Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells. Mol. Cell 2006, 24, 665–675. [Google Scholar] [CrossRef]
  52. Srivastava, S.; Zhdanova, O.; Di, L.; Li, Z.; Albaqumi, M.; Wulff, H.; Skolnik, E.Y. Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K+ channel KCa3. Proc. Natl. Acad. Sci. USA 2008, 105, 14442–14446. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Maekawa, M.; Terasaka, S.; Mochizuki, Y.; Kawai, K.; Ikeda, Y.; Araki, N.; Skolnik, E.Y.; Taguchi, T.; Arai, H. Sequential breakdown of 3-phosphorylated phosphoinositides is essential for the completion of macropinocytosis. Proc. Natl. Acad. Sci. USA 2014, 111, 978–987. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Zhang, Y.; Chu, X.; Liu, L.; Zhang, N.; Guo, H.; Yang, F.; Liu, Z.; Dong, Y.; Bao, Y.; Zhang, X.; et al. Tannic acid activates the Kv7.4 and Kv7.3/7.5 K(+) channels expressed in HEK293 cells and reduces tension in the rat mesenteric arteries. J. Pharm. Pharmacol. 2016, 68, 494–502. [Google Scholar] [CrossRef]
  55. Muller, M.; Slivinski, N.; Todd, E.; Khalid, H.; Li, R.; Karwatka, M.; Merits, A.; Mankouri, J.; Tuplin, A. Chikungunya virus requires cellular chloride channels for efficient genome replication. PLoS Negl. Trop. Dis. 2019, 13, e0007703. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Hansen, T.H.; Yan, Y.; Ahlberg, G.; Vad, O.B.; Refsgaard, L.; Dos Santos, J.L.; Mutsaers, N.; Svendsen, J.H.; Olesen, M.S.; Bentzen, B.H.; et al. A Novel Loss-of-Function Variant in the Chloride Ion Channel Gene Clcn2 Associates with Atrial Fibrillation. Sci. Rep. 2020, 10, 1453. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Leisle, L.; Ludwig, C.F.; Wagner, F.A.; Jentsch, T.J.; Stauber, T. ClC-7 is a slowly voltage-gated 2Cl(-)/1H(+)-exchanger and requires Ostm1 for transport activity. EMBO J. 2011, 30, 2140–2152. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Bourdin, B.; Shakeri, B.; Tetreault, M.P.; Sauve, R.; Lesage, S.; Parent, L. Functional characterization of CaValpha2delta mutations associated with sudden cardiac death. J. Biol. Chem. 2015, 290, 2854–2869. [Google Scholar] [CrossRef] [Green Version]
  59. Yang, L.; Katchman, A.; Morrow, J.P.; Doshi, D.; Marx, S.O. Cardiac L-type calcium channel (Cav1.2) associates with gamma subunits. FASEB J. 2011, 25, 928–936. [Google Scholar] [CrossRef] [Green Version]
  60. Oh, U.; Jung, J. Cellular functions of TMEM16/anoctamin. Pflugers Arch. 2016, 468, 443–453. [Google Scholar] [CrossRef] [Green Version]
  61. Lin, H.; Jun, I.; Woo, J.H.; Lee, M.G.; Kim, S.J.; Nam, J.H. Temperature-dependent increase in the calcium sensitivity and acceleration of activation of ANO6 chloride channel variants. Sci. Rep. 2019, 9, 6706. [Google Scholar] [CrossRef] [Green Version]
  62. Veit, M.; Koyro, K.I.; Ahrens, B.; Bleibaum, F.; Munz, M.; Rovekamp, H.; Andra, J.; Schreiber, R.; Kunzelmann, K.; Sommer, A.; et al. Anoctamin-6 regulates ADAM sheddase function. Biochim. Biophys. Acta Mol. Cell Res. 2018, 1865, 1598–1610. [Google Scholar] [CrossRef] [PubMed]
  63. Lin, H.; Roh, J.; Woo, J.H.; Kim, S.J.; Nam, J.H. TMEM16F/ANO6, a Ca(2+)-activated anion channel, is negatively regulated by the actin cytoskeleton and intracellular MgATP. Biochem. Biophys. Res. Commun. 2018, 503, 2348–2354. [Google Scholar] [CrossRef] [PubMed]
  64. Jha, A.; Chung, W.Y.; Vachel, L.; Maleth, J.; Lake, S.; Zhang, G.; Ahuja, M.; Muallem, S. Anoctamin 8 tethers endoplasmic reticulum and plasma membrane for assembly of Ca(2+) signaling complexes at the ER/PM compartment. EMBO J. 2019, 38, e101452. [Google Scholar] [CrossRef]
  65. Bushell, S.R.; Pike, A.C.W.; Falzone, M.E.; Rorsman, N.J.G.; Ta, C.M.; Corey, R.A.; Newport, T.D.; Christianson, J.C.; Scofano, L.F.; Shintre, C.A.; et al. The structural basis of lipid scrambling and inactivation in the endoplasmic reticulum scramblase TMEM16K. Nat. Commun 2019, 10, 3956. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Ishihara, K.; Suzuki, J.; Nagata, S. Role of Ca(2+) in the Stability and Function of TMEM16F and 16K. Biochemistry 2016, 55, 3180–3188. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Waldmann, R.; Champigny, G.; Bassilana, F.; Heurteaux, C.; Lazdunski, M. A proton-gated cation channel involved in acid-sensing. Nature 1997, 386, 173–177. [Google Scholar] [CrossRef]
  68. Pena-Oyarzun, D.; Batista-Gonzalez, A.; Kretschmar, C.; Burgos, P.; Lavandero, S.; Morselli, E.; Criollo, A. New emerging roles of Polycystin-2 in the regulation of autophagy. Int. Rev. Cell Mol. Biol. 2020, 354, 165–186. [Google Scholar] [CrossRef]
  69. Brailoiu, E.; Churamani, D.; Cai, X.; Schrlau, M.G.; Brailoiu, G.C.; Gao, X.; Hooper, R.; Boulware, M.J.; Dun, N.J.; Marchant, J.S.; et al. Essential requirement for two-pore channel 1 in NAADP-mediated calcium signaling. J. Cell Biol. 2009, 186, 201–209. [Google Scholar] [CrossRef]
  70. Ludwig, A.; Zong, X.; Stieber, J.; Hullin, R.; Hofmann, F.; Biel, M. Two pacemaker channels from human heart with profoundly different activation kinetics. EMBO J. 1999, 18, 2323–2329. [Google Scholar] [CrossRef] [Green Version]
  71. Ahuja, S.; Mukund, S.; Deng, L.; Khakh, K.; Chang, E.; Ho, H.; Shriver, S.; Young, C.; Lin, S.; Johnson, J.P., Jr.; et al. Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist. Science 2015, 350, aac5464. [Google Scholar] [CrossRef] [Green Version]
  72. Huttlin, E.L.; Bruckner, R.J.; Paulo, J.A.; Cannon, J.R.; Ting, L.; Baltier, K.; Colby, G.; Gebreab, F.; Gygi, M.P.; Parzen, H.; et al. Architecture of the human interactome defines protein communities and disease networks. Nature 2017, 545, 505–509. [Google Scholar] [CrossRef] [PubMed]
  73. Coverstone, E.D.; Bach, R.G.; Chen, L.; Bierut, L.J.; Li, A.Y.; Lenzini, P.A.; O’Neill, H.C.; Spertus, J.A.; Sucharov, C.C.; Stitzel, J.A.; et al. A novel genetic marker of decreased inflammation and improved survival after acute myocardial infarction. Basic Res. Cardiol. 2018, 113, 38. [Google Scholar] [CrossRef] [PubMed]
  74. Martina, J.A.; Lelouvier, B.; Puertollano, R. The calcium channel mucolipin-3 is a novel regulator of trafficking along the endosomal pathway. Traffic 2009, 10, 1143–1156. [Google Scholar] [CrossRef] [PubMed]
  75. Handford, C.A.; Lynch, J.W.; Baker, E.; Webb, G.C.; Ford, J.H.; Sutherland, G.R.; Schofield, P.R. The human glycine receptor beta subunit: Primary structure, functional characterisation and chromosomal localisation of the human and murine genes. Brain Res. Mol. Brain Res. 1996, 35, 211–219. [Google Scholar] [CrossRef]
  76. Butler, K.M.; Moody, O.A.; Schuler, E.; Coryell, J.; Alexander, J.J.; Jenkins, A.; Escayg, A. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy. Brain 2018, 141, 2392–2405. [Google Scholar] [CrossRef]
  77. Sharma, J.; Balakrishnan, L.; Kaushik, S.; Kashyap, M.K. Editorial: Multi-Omics Approaches to Study Signaling Pathways. Front. Bioeng. Biotechnol. 2020, 8, 829. [Google Scholar] [CrossRef]
  78. Parthasarathi, K.T.S.; Munjal, N.S.; Dey, G.; Kumar, A.; Pandey, A.; Balakrishnan, L.; Sharma, J. A pathway map of signaling events triggered upon SARS-CoV infection. J. Cell Commun. Signal. 2021, 15, 595–600. [Google Scholar] [CrossRef]
  79. Gao, Y.L.; Du, Y.; Zhang, C.; Cheng, C.; Yang, H.Y.; Jin, Y.F.; Duan, G.C.; Chen, S.Y. Role of Renin-Angiotensin System in Acute Lung Injury Caused by Viral Infection. Infect. Drug Resist. 2020, 13, 3715–3725. [Google Scholar] [CrossRef]
  80. Komatsu, M.; Takei, M.; Ishii, H.; Sato, Y. Glucose-stimulated insulin secretion: A newer perspective. J. Diabetes Investig. 2013, 4, 511–516. [Google Scholar] [CrossRef]
  81. Muller, J.A.; Gross, R.; Conzelmann, C.; Kruger, J.; Merle, U.; Steinhart, J.; Weil, T.; Koepke, L.; Bozzo, C.P.; Read, C.; et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat. Metab. 2021, 3, 149–165. [Google Scholar] [CrossRef]
  82. Ghasemnejad-Berenji, M.; Pashapour, S. SARS-CoV-2 and the Possible Role of Raf/MEK/ERK Pathway in Viral Survival: Is This a Potential Therapeutic Strategy for COVID-19? Pharmacology 2020, 106, 119–122. [Google Scholar] [CrossRef] [PubMed]
  83. Selvaraj, K.; Ravichandran, S.; Krishnan, S.; Radhakrishnan, R.K.; Manickam, N.; Kandasamy, M. Testicular Atrophy and Hypothalamic Pathology in COVID-19: Possibility of the Incidence of Male Infertility and HPG Axis Abnormalities. Reprod. Sci. 2021, 28, 2735–2742. [Google Scholar] [CrossRef] [PubMed]
  84. Jaffal, S.M.; Abbas, M.A. TRP channels in COVID-19 disease: Potential targets for prevention and treatment. Chem. Biol. Interact. 2021, 345, 109567. [Google Scholar] [CrossRef] [PubMed]
  85. Arya, R.; Kumari, S.; Pandey, B.; Mistry, H.; Bihani, S.C.; Das, A.; Prashar, V.; Gupta, G.D.; Panicker, L.; Kumar, M. Structural insights into SARS-CoV-2 proteins. J. Mol. Biol. 2020, 433, 166725. [Google Scholar] [CrossRef]
  86. Snijder, E.J.; Decroly, E.; Ziebuhr, J. The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing. Adv. Virus Res. 2016, 96, 59–126. [Google Scholar] [CrossRef]
  87. Angelini, M.M.; Akhlaghpour, M.; Neuman, B.W.; Buchmeier, M.J. Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. mBio 2013, 4, e00524-13. [Google Scholar] [CrossRef] [Green Version]
  88. Wang, K.; Xie, S.; Sun, B. Viral proteins function as ion channels. Biochim. Biophys. Acta 2010, 1808, 510–515. [Google Scholar] [CrossRef]
  89. Parenti, A.; De Logu, F.; Geppetti, P.; Benemei, S. What is the evidence for the role of TRP channels in inflammatory and immune cells? Br. J. Pharmacol. 2016, 173, 953–969. [Google Scholar] [CrossRef]
  90. Groneberg, D.A.; Niimi, A.; Dinh, Q.T.; Cosio, B.; Hew, M.; Fischer, A.; Chung, K.F. Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am. J. Respir. Crit. Care Med. 2004, 170, 1276–1280. [Google Scholar] [CrossRef]
  91. Talavera, K. TRP Channels as Targets for Modulation of Taste Transduction; Springer: Cham, Switzerland, 2015; pp. 127–140. [Google Scholar] [CrossRef]
  92. Huang, N.; Perez, P.; Kato, T.; Mikami, Y.; Okuda, K.; Gilmore, R.C.; Conde, C.D.; Gasmi, B.; Stein, S.; Beach, M.; et al. SARS-CoV-2 infection of the oral cavity and saliva. Nat. Med. 2021, 27, 892–903. [Google Scholar] [CrossRef]
  93. Wu, L.; Girgis, C.M.; Cheung, N.W. COVID-19 and diabetes: Insulin requirements parallel illness severity in critically unwell patients. Clin. Endocrinol. 2020, 93, 390–393. [Google Scholar] [CrossRef] [PubMed]
  94. Gianchandani, R.; Esfandiari, N.H.; Ang, L.; Iyengar, J.; Knotts, S.; Choksi, P.; Pop-Busui, R. Managing Hyperglycemia in the COVID-19 Inflammatory Storm. Diabetes 2020, 69, 2048–2053. [Google Scholar] [CrossRef] [PubMed]
  95. Ivanova, H.; Vervliet, T.; Missiaen, L.; Parys, J.B.; De Smedt, H.; Bultynck, G. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival. Biochim. Biophys. Acta 2014, 1843, 2164–2183. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Saeedi Saravi, S.S.; Beer, J.H. Apelin-potential therapy for COVID-19? J. Mol. Cell Cardiol. 2020, 145, 84–87. [Google Scholar] [CrossRef]
  97. Scialo, F.; Daniele, A.; Amato, F.; Pastore, L.; Matera, M.G.; Cazzola, M.; Castaldo, G.; Bianco, A. ACE2: The Major Cell Entry Receptor for SARS-CoV. Lung 2020, 198, 867–877. [Google Scholar] [CrossRef]
  98. Wang, C.; Liu, N.; Luan, R.; Li, Y.; Wang, D.; Zou, W.; Xing, Y.; Tao, L.; Cao, F.; Wang, H. Apelin protects sarcoplasmic reticulum function and cardiac performance in ischaemia-reperfusion by attenuating oxidation of sarcoplasmic reticulum Ca2+-ATPase and ryanodine receptor. Cardiovasc. Res. 2013, 100, 114–124. [Google Scholar] [CrossRef] [Green Version]
  99. Feng, J.Y.; Murakami, E.; Zorca, S.M.; Johnson, A.A.; Johnson, K.A.; Schinazi, R.F.; Furman, P.A.; Anderson, K.S. Relationship between antiviral activity and host toxicity: Comparison of the incorporation efficiencies of 2’,3’-dideoxy-5-fluoro-3’-thiacytidine-triphosphate analogs by human immunodeficiency virus type 1 reverse transcriptase and human mitochondrial DNA polymerase. Antimicrob. Agents Chemother. 2004, 48, 1300–1306. [Google Scholar] [CrossRef] [Green Version]
  100. Bruford, E.A.; Lush, M.J.; Wright, M.W.; Sneddon, T.P.; Povey, S.; Birney, E. The HGNC Database in 2008: A resource for the human genome. Nucleic Acids Res. 2008, 36, D445–D448. [Google Scholar] [CrossRef]
  101. Abbasi, W.A.; Yaseen, A.; Hassan, F.U.; Andleeb, S.; Minhas, F. ISLAND: In-silico proteins binding affinity prediction using sequence information. BioData Min. 2020, 13, 20. [Google Scholar] [CrossRef]
  102. Ben-Hur, A.; Noble, W.S. Choosing negative examples for the prediction of protein-protein interactions. BMC Bioinform. 2006, 7 (Suppl. 1), S2. [Google Scholar] [CrossRef] [Green Version]
  103. Ashburner, M.; Ball, C.A.; Blake, J.A.; Botstein, D.; Butler, H.; Cherry, J.M.; Davis, A.P.; Dolinski, K.; Dwight, S.S.; Eppig, J.T.; et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25–29. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Seth Carbon, E.D.; Douglass, E.; Good, B.M.; Unni, D.R.; Harris, N.L.; Mungall, C.J.; Basu, S.; Chisholm, R.L.; Dodson, R.J.; Hartline, E.; et al. The Gene Ontology resource: Enriching a GOld mine. Nucleic Acids Res. 2021, 49, D325–D334. [Google Scholar] [CrossRef]
  105. Chen, K.H.; Wang, T.F.; Hu, Y.J. Protein-protein interaction prediction using a hybrid feature representation and a stacked generalization scheme. BMC Bioinform. 2019, 20, 308. [Google Scholar] [CrossRef] [PubMed]
  106. Ma, Z.; Wang, P.; Gao, Z.; Wang, R.; Khalighi, K. Ensemble of machine learning algorithms using the stacked generalization approach to estimate the warfarin dose. PLoS ONE 2018, 13, e0205872. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  107. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498–2504. [Google Scholar] [CrossRef] [PubMed]
  108. Zhong, J.; Sharma, J.; Raju, R.; Palapetta, S.M.; Prasad, T.S.; Huang, T.C.; Yoda, A.; Tyner, J.W.; van Bodegom, D.; Weinstock, D.M.; et al. TSLP signaling pathway map: A platform for analysis of TSLP-mediated signaling. Database 2014, 2014, bau007. [Google Scholar] [CrossRef] [PubMed]
  109. Kutmon, M.; van Iersel, M.P.; Bohler, A.; Kelder, T.; Nunes, N.; Pico, A.R.; Evelo, C.T. PathVisio 3: An extendable pathway analysis toolbox. PLoS Comput. Biol. 2015, 11, e1004085. [Google Scholar] [CrossRef] [Green Version]
  110. Griffith, M.; Griffith, O.L.; Coffman, A.C.; Weible, J.V.; McMichael, J.F.; Spies, N.C.; Koval, J.; Das, I.; Callaway, M.B.; Eldred, J.M.; et al. DGIdb: Mining the druggable genome. Nat. Methods 2013, 10, 1209–1210. [Google Scholar] [CrossRef]
  111. Freshour, S.L.; Kiwala, S.; Cotto, K.C.; Coffman, A.C.; McMichael, J.F.; Song, J.J.; Griffith, M.; Griffith, O.L.; Wagner, A.H. Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 2021, 49, D1144–D1151. [Google Scholar] [CrossRef]
Figure 1. Depiction of protein–protein interactions of SARS-CoV-2 proteins: (A) E (B) S (C) M (D) ORF7b (E) ORF3a (F) ORF6 (G) ORF7a (H) nsp6 (I) nsp4 (J) ORF8 (K) nsp3 (L) nsp14 (M) nsp5 (N) nsp13 and (O) nsp16 with human ion channels (HICs). Yellow color diamond shaped node represents SARS-CoV-2 proteins and HICs are represented as a blue color diamond.
Figure 1. Depiction of protein–protein interactions of SARS-CoV-2 proteins: (A) E (B) S (C) M (D) ORF7b (E) ORF3a (F) ORF6 (G) ORF7a (H) nsp6 (I) nsp4 (J) ORF8 (K) nsp3 (L) nsp14 (M) nsp5 (N) nsp13 and (O) nsp16 with human ion channels (HICs). Yellow color diamond shaped node represents SARS-CoV-2 proteins and HICs are represented as a blue color diamond.
Pathogens 11 00259 g001
Figure 2. Representation of protein–protein interaction networks of HICs-SARS-CoV-2 proteins: protein–protein interactions of human ion channels (HICs) were generated using STRING database (purple color nodes). Furthermore, HICs interaction networks were overlaid with SARS-CoV-2 proteins (A) M, (B) E, (C) ORF7a (D) S, (E) ORF6, (F) ORF3a, (G) ORF8, (H) ORF7b, (I) nsp6 and (J) nsp4. Yellow color node represents SARS-CoV-2 proteins and human ion channels are represented by the purple color node.
Figure 2. Representation of protein–protein interaction networks of HICs-SARS-CoV-2 proteins: protein–protein interactions of human ion channels (HICs) were generated using STRING database (purple color nodes). Furthermore, HICs interaction networks were overlaid with SARS-CoV-2 proteins (A) M, (B) E, (C) ORF7a (D) S, (E) ORF6, (F) ORF3a, (G) ORF8, (H) ORF7b, (I) nsp6 and (J) nsp4. Yellow color node represents SARS-CoV-2 proteins and human ion channels are represented by the purple color node.
Pathogens 11 00259 g002
Figure 3. Schematic depiction of possible reactions induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via interactions with human ion channels (HICs). The signaling pathway map depicts the biological processes affected upon SARS-CoV-2 infection and the drugs interacting with HICs. The edges representing the relationship between the nodes are provided in the legend.
Figure 3. Schematic depiction of possible reactions induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via interactions with human ion channels (HICs). The signaling pathway map depicts the biological processes affected upon SARS-CoV-2 infection and the drugs interacting with HICs. The edges representing the relationship between the nodes are provided in the legend.
Pathogens 11 00259 g003
Figure 4. Representation of human ion channels-drug target network: potential human ion channels (HICs) (blue color nodes) interacting with SARS-CoV-2 proteins (A) M, (B) E, (C) ORF7a, (D) nsp6, (E) S, (F) ORF8, (G) ORF7b and (H) nsp4 (yellow color nodes) and FDA-approved drugs (black) were depicted on HICs-SARS-CoV-2 protein–protein interaction networks.
Figure 4. Representation of human ion channels-drug target network: potential human ion channels (HICs) (blue color nodes) interacting with SARS-CoV-2 proteins (A) M, (B) E, (C) ORF7a, (D) nsp6, (E) S, (F) ORF8, (G) ORF7b and (H) nsp4 (yellow color nodes) and FDA-approved drugs (black) were depicted on HICs-SARS-CoV-2 protein–protein interaction networks.
Pathogens 11 00259 g004
Figure 5. A schematic overview of the several analyses carried out to study the interactome networks of SARS-CoV-2 proteins with human ion channels.
Figure 5. A schematic overview of the several analyses carried out to study the interactome networks of SARS-CoV-2 proteins with human ion channels.
Pathogens 11 00259 g005
Table 1. Overall performance of PPI-MetaGO.
Table 1. Overall performance of PPI-MetaGO.
AccuracyPrecisionF1 ScoreAUC-ROCMCCSensitivityFalse Positive Rate
82.7184.0984.090.8965.1784.0918.91
Table 2. Confusion matrix obtained from PPI-MetaGO.
Table 2. Confusion matrix obtained from PPI-MetaGO.
True PositiveTrue Negative
Predicted Positive377
Predicted Negative730
Table 3. List of KEGG pathways and potential target HICs.
Table 3. List of KEGG pathways and potential target HICs.
KEGG PathwayPotential Target
Proteins
StrengthFalse Discovery
Rate
Inflammatory mediator
regulation of TRP
channels
ASIC1, TRPA1, ITPR1,
ITPR2, ITPR3
1.460.0000328
Insulin secretionTRPM4, KCNN4,
KCNJ11, ITPR3
1.40.00022
Renin secretionITPR1, ITPR3, ITPR21.40.0012
Gap junctionGJA1, ITPR1, ITPR3,
ITPR2
1.390.00022
Taste transductionGABRA5, ITPR3,
SCN9A
1.290.0017
Calcium signaling
pathway
ITPR1, MCOLN3,
VDAC2, ITPR3,
ITPR2, VDAC3, TPCN1
1.20.0000511
Apelin signaling
pathway
ITPR1, ITPR3, ITPR21.080.004
GnRH secretionHCN2, ITPR1, ITPR2,
ITPR3, KCNN4,
KCNJ11
1.670.00000024
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Munjal, N.S.; Sapra, D.; Parthasarathi, K.T.S.; Goyal, A.; Pandey, A.; Banerjee, M.; Sharma, J. Deciphering the Interactions of SARS-CoV-2 Proteins with Human Ion Channels Using Machine-Learning-Based Methods. Pathogens 2022, 11, 259. https://doi.org/10.3390/pathogens11020259

AMA Style

Munjal NS, Sapra D, Parthasarathi KTS, Goyal A, Pandey A, Banerjee M, Sharma J. Deciphering the Interactions of SARS-CoV-2 Proteins with Human Ion Channels Using Machine-Learning-Based Methods. Pathogens. 2022; 11(2):259. https://doi.org/10.3390/pathogens11020259

Chicago/Turabian Style

Munjal, Nupur S., Dikscha Sapra, K. T. Shreya Parthasarathi, Abhishek Goyal, Akhilesh Pandey, Manidipa Banerjee, and Jyoti Sharma. 2022. "Deciphering the Interactions of SARS-CoV-2 Proteins with Human Ion Channels Using Machine-Learning-Based Methods" Pathogens 11, no. 2: 259. https://doi.org/10.3390/pathogens11020259

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop